Speech-Language Pathologists in Sandpoint, ID Accepting Medicare

10 Speech-Language Pathologists found. Showing 1 - 10

Mr. James Rob Aronow, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 414 Superior St, Sandpoint, ID 83864 Phone: 208-245-4576    Fax: 208-245-2138

Tina L Sleyster, MCSD CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843

Deborah K Faude, MA CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843

Mr. Charles E Kees, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Division Ave, Sandpoint, ID 83864 Phone: 208-265-4514    Fax: 208-263-3789

North Idaho Speech Language Associates Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843    Fax: 208-263-1843

Ms. Jean Gerth, CCC-SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 551 E Sunnyside Rd, Sandpoint, ID 83864 Phone: 208-290-1349

Alyssa Y Jacobson, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843

Ms. Caulene Marie Allen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 520 N Third Ave, Sandpoint, ID 83864 Phone: 208-265-3325    Fax: 208-263-1878

Ms. Lorraine Ann Reigel, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1218 N Division Ave, Sandpoint, ID 83864 Phone: 208-255-7337

Ms. Kaitlin Elizabeth Williams, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843

News Archive

Iksuda Therapeutics closes $47 million financing round

Iksuda Therapeutics (Iksuda) has announced it has completed a US $47 million (circa GB £34 million) financing round, co-led by Mirae Asset Capital and its subsidiaries, Celltrion and Premier Partners, with the Company being advised by Ashfords LLP. The funding will support the advancement of Iksuda's lead ADC assets and expansion of its payload and conjugation platform technologies.

Scientists try to develop portable systems that can quickly produce biologics on demand

Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These "biologics" can be difficult to obtain and store on the battlefield or in remote areas.

Study uses machine learning algorithms to classify word type based on brain activity

Pairing machine learning with neuroimaging can determine whether a person heard a real or made up word based on their brain activity, according to a new study published in eNeuro.

Dapagliflozin as monotherapy demonstrates potential for type 2 diabetes treatment

Findings from a 24-week Phase 3 clinical study published online in the latest issue of Diabetes Care demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of glycosylated hemoglobin levels (HbA1c) in treatment-naïve adult patients with newly diagnosed type 2 diabetes, compared to placebo.

Read more Medical News

› Verified 4 days ago